Moderna

Showing 15 posts of 32 posts found.

Merck and Moderna initiate phase 3 study of NSCLC treatment

December 13, 2023
Medical Communications Merck, Moderna, NSCLC, Oncology, clinical trial

Merck (known as MSD outside of the US and Canada) and Moderna have announced the initiation of the phase 3 …

diana-polekhina-zbsthwt9vlc-unsplash_2

Moderna shares data from phase 1/2 trial for combination flu and COVID-19 vaccine

October 5, 2023
Research and Development COVID-19, Immunology, Moderna, clinical trial, influenza, vaccines

Moderna has announced positive interim results from the phase 1/2 trial of mRNA-1083, its investigational combination vaccine against influenza and …

study_participant_receives_niaid-gsk_candidate_ebola_vaccine

Moderna files for FDA authorisation for updated COVID-19 vaccine

June 23, 2023
Research and Development COVID-19, FDA, Immunology, Moderna, Vaccine

Biotechnology company Moderna has announced that it has completed submission of a regulatory application to the US Food and Drug …

Health Canada announce first full approval for Moderna COVID-19 vaccine

September 17, 2021
Medical Communications AstraZeneca, BioNTech, Health Canada, Moderna, Pfizer, mrna

Canada has become the first country in the world to grant full approval to the Moderna vaccine, alongside confirmation for …

moderna_norwood_plant

Moderna and Pfizer COVID-19 vaccine protection declines over time

September 16, 2021
Business Services COVID-19, FDA, Moderna, Pfizer, comirnaty

Data presented by Pfizer and Moderna ahead of the FDA’s vaccine advisory committee meeting on Friday suggest that protection from …

moderna_norwood_plant

Moderna submits BLA with FDA for COVID vaccine

June 2, 2021
Research and Development COVID-19, EU, FDA, Lonza, Moderna, production

Moderna has initiated the rolling submission process with the FDA for a Biologics License Application (BLA) for the licensure of …

Australian PM calls for domestic mRNA vaccine production

May 21, 2021
Medical Communications Australia, Moderna, Vaccine, mrna

Australian Prime Minister, Scott Morrison, has invited proposals from pharmaceutical firms to establish domestic manufacturing of mRNA vaccines, to strengthen …

Moderna building

COVID-19: Moderna booster shots appear to increase immunity

May 6, 2021
COVID-19, COVID-19 vaccine, Moderna, covid news, pharma, pharma news

Moderna’s mRNA booster jabs for people already vaccinated against COVID-19 have shown positive initial data in a Phase II study …

moderna_norwood_plant

Moderna to supply up to 500 million COVID-19 vaccines to COVAX

May 4, 2021
Manufacturing and Production, Sales and Marketing COVAX, COVID-19, Moderna, Vaccine, WHO

Moderna have announced a supply agreement with Gavi, the Vaccine Alliance, for up to 500 million doses of their COVID-19 …

moderna_norwood_plant

Moderna up investments to produce 3 billion COVID vaccine doses in 2022

April 29, 2021
COVID-19, Moderna, Vaccine, investment

Moderna have announced it is making new funding commitments to increase supply at its owned and partnered manufacturing facilities, which …

Moderna building

UK begins rollout of Moderna COVID-19 vaccine

April 7, 2021
Research and Development COVID-19, COVID-19 vaccine, Moderna, Moderna vaccine, pharma, pharma news

The first Moderna COVID-19 vaccine in the UK has today been administered, beginning the rollout of the country’s third vaccine …

moderna_norwood_plant

500,000 Moderna COVID-19 vaccines to arrive in UK next month

March 29, 2021
Sales and Marketing COVID-19, Moderna, Vaccine

More than 500,000 doses of Moderna’s COVID-19 vaccine are set to arrive in the UK next month, ministers have confirmed. …

Florida woman gives birth to first-known baby born with COVID-19 antibodies

March 18, 2021
COVID-19, Moderna, Vaccine

A woman from Florida has given birth to the first-known baby born with COVID-19 antibodies, according to findings recently published …

moderna_norwood_plant

Switzerland approves Moderna’s COVID-19 vaccine

January 13, 2021
Research and Development COVID-19, Moderna, Vaccine

Moderna has announced that its COVID-19 vaccine has been authorised for use on those aged 18 or older in Switzerland. …

moderna_norwood_plant

EU approves Moderna’s COVID-19 vaccine

January 7, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Moderna, Vaccine

The European Commission has granted a Condition Marketing Authorisation (CMA) for Moderna’s COVID-19 vaccine, meaning the jab will soon be …

Latest content